These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 27601496)

  • 21. Clinical effectiveness and cost-effectiveness of beta-interferon and glatiramer acetate for treating multiple sclerosis: systematic review and economic evaluation.
    Melendez-Torres GJ; Auguste P; Armoiry X; Maheswaran H; Court R; Madan J; Kan A; Lin S; Counsell C; Patterson J; Rodrigues J; Ciccarelli O; Fraser H; Clarke A
    Health Technol Assess; 2017 Sep; 21(52):1-352. PubMed ID: 28914229
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cost-effectiveness of treatment for chronic hepatitis C infection in an evolving patient population.
    Salomon JA; Weinstein MC; Hammitt JK; Goldie SJ
    JAMA; 2003 Jul; 290(2):228-37. PubMed ID: 12851278
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The safety and effectiveness of different methods of earwax removal: a systematic review and economic evaluation.
    Clegg AJ; Loveman E; Gospodarevskaya E; Harris P; Bird A; Bryant J; Scott DA; Davidson P; Little P; Coppin R
    Health Technol Assess; 2010 Jun; 14(28):1-192. PubMed ID: 20546687
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cost-effectiveness and budget impact analysis of facility-based screening and treatment of hepatitis C in Punjab state of India.
    Chugh Y; Premkumar M; Grover GS; Dhiman RK; Teerawattananon Y; Prinja S
    BMJ Open; 2021 Feb; 11(2):e042280. PubMed ID: 33589457
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Economic evaluation of HCV testing approaches in low and middle income countries.
    Morgan JR; Servidone M; Easterbrook P; Linas BP
    BMC Infect Dis; 2017 Nov; 17(Suppl 1):697. PubMed ID: 29143681
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The emergency department as a setting-specific opportunity for population-based hepatitis C screening: An economic evaluation.
    Mendlowitz AB; Naimark D; Wong WWL; Capraru C; Feld JJ; Isaranuwatchai W; Krahn M
    Liver Int; 2020 Jun; 40(6):1282-1291. PubMed ID: 32267604
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A systematic review of economic evaluations of screening programmes for cardiometabolic diseases.
    Hiligsmann M; Wyers CE; Mayer S; Evers SM; Ruwaard D
    Eur J Public Health; 2017 Aug; 27(4):621-631. PubMed ID: 28040737
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Computerised decision support systems in order communication for diagnostic, screening or monitoring test ordering: systematic reviews of the effects and cost-effectiveness of systems.
    Main C; Moxham T; Wyatt JC; Kay J; Anderson R; Stein K
    Health Technol Assess; 2010 Oct; 14(48):1-227. PubMed ID: 21034668
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Optimization of hepatitis C virus screening strategies by birth cohort in Italy.
    Kondili LA; Gamkrelidze I; Blach S; Marcellusi A; Galli M; Petta S; Puoti M; Vella S; Razavi H; Craxi A; Mennini FS;
    Liver Int; 2020 Jul; 40(7):1545-1555. PubMed ID: 32078234
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Screening for Hepatitis C in injecting drug users: a cost utility analysis.
    Stein K; Dalziel K; Walker A; Jenkins B; Round A; Royle P
    J Public Health (Oxf); 2004 Mar; 26(1):61-71. PubMed ID: 15044577
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Short-Term Effects and Long-Term Cost-Effectiveness of Universal Hepatitis C Testing in Prenatal Care.
    Tasillo A; Eftekhari Yazdi G; Nolen S; Schillie S; Vellozzi C; Epstein R; Randall L; Salomon JA; Linas BP
    Obstet Gynecol; 2019 Feb; 133(2):289-300. PubMed ID: 30633134
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HCV screening to enable early treatment of hepatitis C: a mathematical model to analyse costs and outcomes in two populations.
    Tramarin A; Gennaro N; Compostella FA; Gallo C; Wendelaar Bonga LJ; Postma MJ
    Curr Pharm Des; 2008; 14(17):1655-60. PubMed ID: 18673188
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunosuppressive therapy for kidney transplantation in children and adolescents: systematic review and economic evaluation.
    Haasova M; Snowsill T; Jones-Hughes T; Crathorne L; Cooper C; Varley-Campbell J; Mujica-Mota R; Coelho H; Huxley N; Lowe J; Dudley J; Marks S; Hyde C; Bond M; Anderson R
    Health Technol Assess; 2016 Aug; 20(61):1-324. PubMed ID: 27557331
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cost effectiveness of an intervention to increase uptake of hepatitis C virus testing and treatment (HepCATT): cluster randomised controlled trial in primary care.
    Roberts K; Macleod J; Metcalfe C; Hollingworth W; Williams J; Muir P; Vickerman P; Clement C; Gordon F; Irving W; Waldron CA; North P; Moore P; Simmons R; Miners A; Horwood J; Hickman M
    BMJ; 2020 Feb; 368():m322. PubMed ID: 32102782
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The impact of timing and prioritization on the cost-effectiveness of birth cohort testing and treatment for hepatitis C virus in the United States.
    McEwan P; Ward T; Yuan Y; Kim R; L'italien G
    Hepatology; 2013 Jul; 58(1):54-64. PubMed ID: 23389841
    [TBL] [Abstract][Full Text] [Related]  

  • 36. What is the cost utility of screening for hepatitis C virus (HCV) in intravenous drug users?
    Leal P; Stein K; Rosenberg W
    J Med Screen; 1999; 6(3):124-31. PubMed ID: 10572842
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Screening for hepatitis C in genito-urinary medicine clinics: a cost utility analysis.
    Stein K; Dalziel K; Walker A; Jenkins B; Round A; Royle P
    J Hepatol; 2003 Nov; 39(5):814-25. PubMed ID: 14568266
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Early Treatment in HCV: Is it a Cost-Utility Option from the Italian Perspective?
    Marcellusi A; Viti R; Damele F; Cammà C; Taliani G; Mennini FS
    Clin Drug Investig; 2016 Aug; 36(8):661-72. PubMed ID: 27234943
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunosuppressive therapy for kidney transplantation in adults: a systematic review and economic model.
    Jones-Hughes T; Snowsill T; Haasova M; Coelho H; Crathorne L; Cooper C; Mujica-Mota R; Peters J; Varley-Campbell J; Huxley N; Moore J; Allwood M; Lowe J; Hyde C; Hoyle M; Bond M; Anderson R
    Health Technol Assess; 2016 Aug; 20(62):1-594. PubMed ID: 27578428
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.